Tech Company Financing Transactions

Mozart Therapeutics Funding Round

Arch Venture Partners, Sofinnova Ventures and Alexandria Venture Investments participated in a $55 million Series A capital raise for Mozart Therapeutics. The financing round closed on 10/30/2021.

Transaction Overview

Company Name
Mozart Therapeutics
Announced On
10/30/2021
Transaction Type
Venture Equity
Amount
$55,000,000
Round
Series A
Investors

Arch Venture Partners (Lead Investor) (Steve Gillis)

Sofinnova Ventures (Lead Investor) (Henrijette Richter)

Alexandria Venture Investments

Altitude Life Science Ventures

Eli Lilly and Company (Julie Gilmore)

Leaps by Bayer (Lucio Iannone)

MRL Ventures (Peter Dudek)

Proceeds Purpose
The company will use the Series A funds to progress its lead CD8 Treg Modulator into the clinic while also advancing additional programs generated from its novel platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
410 West Harrison St. 150
Seattle, WA 98119
USA
Phone
Undisclosed
Website
www.mozart-tx.com
Email Address
[email protected]
Overview
Mozart Therapeutics is focused on developing disease-modifying therapies for autoimmune and inflammatory diseases that work by targeting a novel regulatory immune pathway. The therapeutic focus of Mozart's lead program is autoimmune mediated gastro-intestinal disorders. The company is headquartered in Seattle, WA.
Profile
Mozart Therapeutics LinkedIn Company Profile
Social Media
Mozart Therapeutics Company Twitter Account
Company News
Mozart Therapeutics News
Facebook
Mozart Therapeutics on Facebook
YouTube
Mozart Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Steven Gillis
  Steven Gillis LinkedIn Profile  Steven Gillis Twitter Account  Steven Gillis News  Steven Gillis on Facebook
Chief Executive Officer
Katie Fanning
  Katie Fanning LinkedIn Profile  Katie Fanning Twitter Account  Katie Fanning News  Katie Fanning on Facebook
Chief Scientific Officer
Kristine Swiderek
  Kristine Swiderek LinkedIn Profile  Kristine Swiderek Twitter Account  Kristine Swiderek News  Kristine Swiderek on Facebook
Vice President
Courtney Crane
  Courtney Crane LinkedIn Profile  Courtney Crane Twitter Account  Courtney Crane News  Courtney Crane on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/30/2021: GigLabs venture capital transaction
Next: 10/30/2021: Ladder venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.